Dual PI3K/mTOR inhibition with BEZ235 in patient-derived OSCC cells or prostate cancer cell lines.Treatment of OSCC cell lines with RAD001 inhibitor decreases the phosphorylation and activation of mTOR and increases the RR. Here, MTOR is linked to prostate carcinoma.